4
Changes in Ownership
Q/C TECHNOLOGIES, INC. Filed Acc 0001683168-26-009018
10% owner acquired 4,982,272 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PharmaCyte Biotech, Inc. · 10% owner
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-18 | Option exercise : show line 1 in the form | +4,982,272 | 5,152,000 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-18 | Option exercise : show line 2 in the form Series G Long-Term Warrants | −851,304 | 2029-05-23 | 9,251,513 | 13,318,344 | D |
| 2026-11-18 | Other acquisition : show line 3 in the form Series H Convertible Preferred Stock | +3,000 | 2027-09-02 | 9,674,299 | 3,000 | D |
Loading xslF345X06/ownership.xml…